Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.55 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16174482 | 0.92 | AOC3 (0.54) | UGT2B7AOC3CYP1A2CYP2A6SLC6A2 | |
| SCHEMBL8582858 | 0.82 | CYP1A2 (0.55) | CYP1A2CYP2A6TSHRTDP1 | |
| SCHEMBL1753651 | 0.81 | UGT2B7 (0.59) | UGT2B7AOC3CYP1A2CYP2A6SLC6A2 | |
| SCHEMBL1070797 | 0.81 | ABCB11 (0.58) | CYP1A2CYP2A6TSHRTDP1 | |
| SCHEMBL7699358 | 0.79 | UGT2B7 (0.52) | UGT2B7AOC3CYP1A2CYP2A6SLC6A2 | |
| SCHEMBL2650436 | 0.79 | UGT2B7 (0.52) | UGT2B7AOC3CYP1A2CYP2A6SLC6A2 | |
| SCHEMBL20976148 | 0.79 | UGT2B7 (0.62) | UGT2B7AOC3CYP1A2CYP2A6SLC6A2 | |
| SCHEMBL15345447 | 0.79 | AOC3 (0.54) | UGT2B7AOC3CYP1A2CYP2A6SLC6A2 | |
| SCHEMBL21137385 | 0.78 | UGT2B7 (0.42) | UGT2B7AOC3CYP1A2CYP2A6SLC6A2 | |
| SCHEMBL9179436 | 0.77 | UGT2B7 (0.71) | UGT2B7AOC3CYP1A2CYP2A6CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116003488-A | Glycosyl donor for beta selective glycosylation reaction, and preparation method and application thereof | 中山大学 | 2023-04-25 | — | — | CN | claimed |
| CN-113214335-A | Lipid X intermediate and preparation method thereof | 上海医药工业研究院 | 2021-08-06 | — | — | CN | claimed |
| US-7582737-B2 | Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides | ACADEMIA SINICA (TW) | 2009-09-01 | — | — | US | claimed |
| WO-2024168123-A1 | SYNTHESIS OF CORE 2 O-SIALYL LEWIS-X POLYSACCHARIDES | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| CN-113527386-B | Intermediate of vaccine adjuvant MPLA, synthesis and application | 上海医药工业研究院 | 2024-03-29 | — | — | CN | disclosed |
| CN-113527050-B | Intermediate of vaccine adjuvant MPLA, synthesis and application | 上海医药工业研究院 | 2024-02-02 | — | — | CN | disclosed |
| CN-113527397-B | Intermediate of vaccine adjuvant MPLA, synthesis and application | 上海医药工业研究院 | 2024-02-02 | — | — | CN | disclosed |
| CN-113527396-B | Intermediate of vaccine adjuvant MPLA, synthesis and application | 上海医药工业研究院 | 2024-02-02 | — | — | CN | disclosed |
| CN-117362375-A | Intermediate for synthesizing 3D-MPL, preparation method and application thereof | 成都迈科康生物科技有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-113527384-B | Intermediate of vaccine adjuvant MPLA, synthesis and application | 上海医药工业研究院 | 2023-10-27 | — | — | CN | disclosed |
| CN-113527382-B | Intermediate of vaccine adjuvant MPLA, synthesis and application | 上海医药工业研究院 | 2023-09-29 | — | — | CN | disclosed |
| WO-2020132625-A1 | SYNTHESIS OF DISACCHARIDE BLOCKS FROM NATURAL POLYSACCHARIDES FOR HEPARAN SULFATE OLIGOSACCHARIDE ASSEMBLY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2020-06-25 | — | — | WO | disclosed |
| CN-107880082-A | 6 \" O function bases KRN7000 of one kind preparation method | 复旦大学 | 2018-04-06 | — | — | CN | disclosed |
| CN-103534238-B | Total synthesis of redox active 1, 4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistosomimetics | 国家科研中心 | 2018-01-02 | — | — | CN | disclosed |
| CN-104994845-A | Quinone based nitric oxide donating compounds for ophthalmic use | NICOX SA | 2015-10-21 | — | — | CN | disclosed |
| EP-0788504-B1 | STEREODIRECTED PROCESS FOR SYNTHESIS OF ALPHA-N-ACETYLGALACTOSAMINIDES | BIOMIRA INC (CA) | 2002-09-04 | — | — | EP | disclosed |
| US-5837830-A | CHEMICAL INTERMEDIATES OFR PREPARING OLIGOSACCHARIDES, GLYCOSYLAMINO ACIDS, GLYCOPEPTIDES WHICH ARE USEFUL IN TREATING AND DIAGNOSING CANCERS AND OTHER DISEASES | BIOMIRA, INC. (CA) | 1998-11-17 | — | — | US | disclosed |
| EP-0788504-A1 | STEREODIRECTED PROCESS FOR SYNTHESIS OF ALPHA-N-ACETYLGALACTOSAMINIDES | BIOMIRA, INC. (CA) | 1997-08-13 | — | — | EP | disclosed |
| US-5527891-A | REACTING N-ACETYLGALACTOSAMINE WITH DIALKYL ACETAL OF ALDEHYDE OR KETONE, PROTECTING 3-HYDROXY GROUP, INTRODUCING ANOMERIC GROUP TO FORM GLYCOSYL DONOR, REACTING WITH ALCOHOL | BIOMIRA, INC. (CA) | 1996-06-18 | — | — | US | disclosed |
| WO-1995024701-A1 | STEREODIRECTED PROCESS FOR SYNTHESIS OF α-N-ACETYLGALACTOSAMINIDES | BIOMIRA, INC. (CA) | 1995-09-14 | — | — | WO | disclosed |